Dr Reddys American Depository Receipts listed on NSE International Exchange
Hyderabad and Princeton: Dr. Reddy's Laboratories Ltd. has recently announced the secondary listing of its American Depository Receipts (ADRs) on NSE IFSC Limited under the symbol 'DRREDDY' on December 9, 2020.
NSE IFSC Limited is a recognized international stock exchange established in the International Financial Services Centre ("IFSC"), GIFT City Gujarat, India. IFSC is one of the permissible jurisdictions where Depository Receipts can be listed on Framework for issuance of Depository Receipts and IFSC Authority on Depository Receipts in the IFSC.
The said listing will provide a secondary platform (other than NYSE Inc.) to overseas investors for trading in Dr. Reddy's ADRs. This is a secondary listing of ADRs that are currently issued by J.P. Morgan Chase Bank N.A. under its ADR Deposit agreement with Dr. Reddy's, and no further capital raising or issuance of new securities is involved. The clearing and settlement of ADRs will be done by NSE IFSC Clearing Corporation Limited through depository account maintained with Clearstream using Internal (Clearstream to Clearstream), Bridge (Clearstream-Euroclear) and Clearstream Domestic links to American market for settlement with Depository Trust Company (DTC) US settlement systems.
Read also: Dr Reddys, RDIF begin Sputnik V clinical trials in India
Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company headquartered in Hyderabad, committed to providing affordable and innovative medicines for healthier lives.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.